Gain Therapeutics, Inc. Profile Avatar - Palmy Investing

Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancemen…

Biotechnology
US, Bethesda [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Gain Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Gain Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Gain Therapeutics, Inc..

End of GANX's Analysis
CIK: 1819411 CUSIP: 36269B105 ISIN: US36269B1052 LEI: - UEI: -
Secondary Listings
GANX has no secondary listings inside our databases.